​

Elicio Therapeutics Ownership | Who Owns Elicio Therapeutics?

OverviewRevenueFinancialsChart

Elicio Therapeutics Ownership Summary

Elicio Therapeutics is owned by 12.06% institutional investors, 36.77% insiders, and 51.17% retail investors. Knoll capital management is the largest institutional shareholder, holding 3.93% of ELTX shares.

ELTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockElicio Therapeutics12.06%36.77%51.17%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Knoll capital management630.91K3.93%$6.90M
Vanguard group473.86K2.95%$5.18M
Geode capital management129.69K0.81%$1.42M
Marshall wace, llp86.53K0.54%$946.67K
Northern trust53.58K0.33%$586.21K
Renaissance48.67K0.30%$532.46K
Blackrock funding, inc. /de44.20K0.28%$483.49K
State street38.30K0.24%$419.00K
Cresset asset management26.93K0.17%$294.56K
Meyer handelman13.90K0.09%$152.06K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Knoll capital management630.91K3.70%$6.90M
Cm management6.00K0.05%$65.64M
Mayflower financial advisors10.00K0.01%$109.40K
Moody lynn & lieberson10.00K0.01%$109.40K
Meyer handelman13.90K0.00%$152.06K
Cresset asset management26.93K0.00%$294.56K
Marshall wace, llp86.53K0.00%$946.67K
Wiley bros.-aintree capital10.00K0.00%$109.40K
Renaissance48.67K0.00%$532.46K
Jefferies financial group5.20K0.00%$56.89M

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp86.53K0.00%86.53K
Renaissance48.67K0.00%48.67K
Cresset asset management26.93K0.00%26.93K
Vanguard group473.86K0.00%19.24K
State street38.30K-16.70K

Top Sellers

HolderShares% AssetsChange
Hudson bay capital management lp---182.73K
Quantinno capital management lp---20.00K
Cm management6.00K0.05%-19.00K
Jane street group---14.99K
Raymond james financial---6.00K

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp86.53K0.00%86.53K$946.67K
Renaissance48.67K0.00%48.67K$532.46K
Cresset asset management26.93K0.00%26.93K$294.56K
Citigroup10.66K0.00%10.66K$116.60K
Jefferies financial group5.20K0.00%5.20K$56.89M

Sold Out

HolderChange
Jpmorgan chase-16.00
Bnp paribas arbitrage, snc-82.00
Raymond james financial-6.00K
Jane street group-14.99K
Quantinno capital management lp-20.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20253134.78%1,936,27333.46%1214.77%20100.00%2-60.00%
Jun 30, 202523-4.17%1,450,816-8.85%95.98%10-41.18%5150.00%
Mar 31, 20252441.18%1,591,744250.55%1288.77%17325.00%2-66.67%
Dec 31, 202417-5.56%454,072-7.61%328.42%4-60.00%6500.00%
Sep 30, 202418-5.26%491,473-24.23%310.95%10-23.08%1-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 12, 2024Chudnovsky Yekaterina Buy$20.00M
Jun 28, 2024Venkatesan Jay-Buy$250.00K
Jun 28, 2024Venkatesan Jay-Buy$500.00
Jun 28, 2024Chudnovsky Yekaterina Buy$8.00M
Jun 28, 2024Chudnovsky Yekaterina Buy$16.00K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q31-
2024 Q24-

ELTX Ownership FAQ

Who Owns Elicio Therapeutics?

Elicio Therapeutics shareholders are primarily institutional investors at 12.06%, followed by 36.77% insiders and 51.17% retail investors. The average institutional ownership in Elicio Therapeutics's industry, Biotech Stocks , is 45.24%, which Elicio Therapeutics falls below.

Who owns the most shares of Elicio Therapeutics?

Elicio Therapeutics’s largest shareholders are Knoll capital management (630.92K shares, 3.93%), Vanguard group (473.86K shares, 2.95%), and Geode capital management (129.69K shares, 0.81%). Together, they hold 7.69% of Elicio Therapeutics’s total shares outstanding.

Does Blackrock own Elicio Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Elicio Therapeutics.

Who is Elicio Therapeutics’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Elicio Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.70% of its assets in 630.92K Elicio Therapeutics shares, valued at 6.9M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools